
Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the updated 2023 EULAR recommendations for PsA and the im...
12 Aug 202428min

Discussing AxSpA: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab
Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Baral...
12 Aug 202429min

IMID Author Interview: Dr Blanca Hernández-Cruz, 2024
Join Professor Peter Nash from the Griffith University in Brisbane, and Blanca Hernández-Cruz, a rheumatologist at Virgen Macarena University Hospital in Seville, as they discuss her recent paper ‘Jan...
12 Aug 202433min

Discussing PsA: Bimekizumab therapy in PsA
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the latest publication by Su, et al. and discuss the late...
12 Aug 202429min

Discussing AxSpA: Upadacitinib in nr-axSpA and certolizumab pegol by baseline MRI and CRP status
Join us for the latest axSpA podcast brought to you by the Immune- ediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda and Xenofon Baraliakos to discu...
12 Aug 202422min

Discussing PsA: Guselkumab and analysis of genetic markers
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, the conversation covered the post hoc analysis of PsA patients receivin...
12 Aug 202425min

Author Interview: Dr Adam Goldman, 2024
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Adam Goldman, an epidemiology researcher at The Chaim Sheba Medical Center in Tel-Hashomer, and an epidemiology researcher an...
8 Aug 202421min

Author Interview: Professor Daniel Blockmans, 2024
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Daniel Blockmans, from the Department of Internal Medicine at the University Hospitals Leuven, as they discuss his rec...
25 Jul 202426min



















